Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostanoid receptors are a family of G protein-coupled receptors (GPCRs) that mediate the actions of prostanoids, including prostaglandins and thromboxanes. These receptors play critical roles in numerous physiological and pathophysiological processes, including inflammation, pain perception, vascular tone regulation, immune modulation, and cell survival. There are at least eight main types/subtypes: DP(1/2), EP(1–4), FP, IP, and TP. Each receptor subtype has distinct ligand-binding properties and couples with specific G-proteins, leading to varied downstream effects.
Selective agonists/antagonists modulate receptor activity and downstream signaling pathways (e.g., cAMP levels, intracellular signaling cascades) associated with specific G-protein coupling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostanoid Receptors (N/A).